Abstract

• Cancer vaccines aim to harness or reactivate the body’s own natural defenses against tumors. • Nanoscale metal-organic-framework (nMOF) generates cytotoxic reactive oxygen species on X-ray exposure. • nMOFs can release tumor antigens and deliver CpG oligonucleotides to boost immune response. • nMOF-based cancer vaccination approach could address problem of tumor heterogeneity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call